Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients
Autor: | Stefan Ziesing, Matthias Eder, V Panagiota, Daniel Kharazipour, Robin Bollin, Sophie Charlotte Hintze, Gernot Beutel, Catherina Lueck, Maleen Beck, Claas Baier, Franz-Christoph Bange, Ella Ebadi |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Microbiology (medical) Colonization Adult Male medicine.medical_specialty medicine.drug_class Carbapenem resistance medicine.medical_treatment 030106 microbiology Antibiotics Short Report Context (language use) Drug resistance Hematopoietic stem cell transplantation Bloodstream infection beta-Lactam Resistance lcsh:Infectious and parasitic diseases 03 medical and health sciences 0302 clinical medicine Medical microbiology Internal medicine Gram-Negative Bacteria medicine Prevalence Infection control Humans Pharmacology (medical) lcsh:RC109-216 Public Health Surveillance Aged Infection Control biology Transmission (medicine) business.industry Public Health Environmental and Occupational Health Hematopoietic Stem Cell Transplantation Middle Aged biology.organism_classification Transplant Recipients Acinetobacter baumannii Anti-Bacterial Agents Infectious Diseases Carbapenems Screening Female business Gram-Negative Bacterial Infections 030215 immunology |
Zdroj: | Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-5 (2019) Antimicrobial Resistance and Infection Control |
ISSN: | 2047-2994 |
Popis: | Hematopoietic stem cell transplantation (HSCT) is a curative treatment option for selected diseases of the hematopoietic system. In the context of HSCT, bloodstream infections caused by Gram-negative bacteria (GNB) significantly contribute to morbidity and mortality. Antibiotic treatment of bloodstream infections with carbapenem-resistant (CR) GNB presents a particular challenge. As a part of our infection control management, the admission of a patient who was known to be colonized with a CR Acinetobacter baumannii triggered an active weekly screening of all patients to determine the prevalence and potential transmission of CR GNB and CR Acinetobacter baumannii in particular. Over a 3 month period a total of 71 patients were regularly screened for colonization with CR GNB. Including the index patient, a total of three patients showed CR GNB colonization representing a prevalence of 4.2%. Nosocomial transmission of CR Acinetobacter baumannii or other CR GNB was not observed. However, the index patient developed a subsequent bloodstream infection with the CR Acinetobacter baumannii, therefore empiric antibiotic therapy based on the known resistance profile was initiated. A weekly prevalence screening for CR GNB might be an effective monitoring tool for potential transmission, may enhance existing infection control management concepts and may support the decision making for empiric antibiotic therapy. |
Databáze: | OpenAIRE |
Externí odkaz: |